Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 11/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | CASP2 | P42575 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3373268 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL37597 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL10589508 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL37783 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL3369909 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| Hydrochloric Acid SCHEMBL8041489 | 0.98 | EPHX1 (0.50) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| Bromide SCHEMBL1459266 | 0.98 | EPHX1 (0.50) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| Hydrochloric Acid SCHEMBL28937648 | 0.98 | EPHX1 (0.50) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL3370320 | 0.97 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL3369009 | 0.90 | EPHX1 (0.41) | EPHX1TSHRALDH1A1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3174554-A1 | NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF | Boehringer Ingelheim Vetmedica GmbH (DE) | 2017-06-07 | — | — | EP | claimed |
| WO-2016016401-A1 | NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2016-02-04 | — | — | WO | claimed |
| US-20160030349-A1 | NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2016-02-04 | — | — | US | claimed |
| EP-0805678-B1 | SURFACE-MODIFIED NANOPARTICLES AND METHOD OF MAKING AND USING SAME | UNIV MICHIGAN (US) | 2003-10-29 | — | — | EP | claimed |
| EP-0760519-B1 | Process for manufacturing nuclear fuel pellets based on (U,PU)02 with addition of an organic sulphur zwitterion compound | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 1999-07-07 | — | — | EP | claimed |
| US-5841200-A | Process for the production of nuclear fuel pellets based on mixed (U, Pu)O2 oxide with the addition of an organic, sulphur product | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1998-11-24 | — | — | US | claimed |
| EP-0805678-A1 | SURFACE-MODIFIED NANOPARTICLES AND METHOD OF MAKING AND USING SAME | THE BOARD OF REGENTS acting for and on behalf of THE UNIVERSITY OF MICHIGAN (US) | 1997-11-12 | — | — | EP | claimed |
| WO-1996020698-A2 | SURFACE-MODIFIED NANOPARTICLES AND METHOD OF MAKING AND USING SAME | THE BOARD OF REGENTS ACTING FOR AND ON BEHALF OF THE UNIVERSITY OF MICHIGAN (US) | 1996-07-11 | — | — | WO | claimed |
| EP-4701672-A1 | INJECTABLE SHEAR-THINNING COMPOSITIONS AND USES THEREOF | Boston Scientific Scimed Inc. (US) | 2026-03-04 | — | — | EP | disclosed |
| US-20240358892-A1 | INJECTABLE SHEAR-THINNING COMPOSITIONS AND USES THEREOF | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-10-31 | — | — | US | disclosed |
| WO-2024226987-A1 | INJECTABLE SHEAR-THINNING COMPOSITIONS AND USES THEREOF | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| EP-3174554-A1 | NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF | Boehringer Ingelheim Vetmedica GmbH (DE) | 2017-06-07 | — | — | EP | disclosed |
| US-20160030349-A1 | NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2016-02-04 | — | — | US | disclosed |
| WO-2016016401-A1 | NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2016-02-04 | — | — | WO | disclosed |
| EP-0805678-B1 | SURFACE-MODIFIED NANOPARTICLES AND METHOD OF MAKING AND USING SAME | UNIV MICHIGAN (US) | 2003-10-29 | — | — | EP | disclosed |
| US-5841200-A | Process for the production of nuclear fuel pellets based on mixed (U, Pu)O2 oxide with the addition of an organic, sulphur product | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1998-11-24 | — | — | US | disclosed |
| WO-1998033478-A2 | RNA- AND DNA-BASED ACTIVE AGENTS IN NANOPARTICLES | ZW BIOMEDICAL RESEARCH AG (CH) | 1998-08-06 | — | — | WO | disclosed |
| EP-0805678-A1 | SURFACE-MODIFIED NANOPARTICLES AND METHOD OF MAKING AND USING SAME | THE BOARD OF REGENTS acting for and on behalf of THE UNIVERSITY OF MICHIGAN (US) | 1997-11-12 | — | — | EP | disclosed |
| EP-0760519-A1 | Process for manufacturing nuclear fuel pellets based on (U,PU)02 with addition of an organic sulphur compound | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1997-03-05 | — | — | EP | disclosed |
| WO-1996020698-A2 | SURFACE-MODIFIED NANOPARTICLES AND METHOD OF MAKING AND USING SAME | THE BOARD OF REGENTS ACTING FOR AND ON BEHALF OF THE UNIVERSITY OF MICHIGAN (US) | 1996-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160030349-A1 | NANOPARTICLES, METHODS OF PREPARATION, AND USES THEREOF | MYD88, TLR3, CD63 | EPHX1 1012/4885TSHR 4703/4885ALDH1A1 2968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.